Cargando…

Licoflavone A Suppresses Gastric Cancer Growth and Metastasis by Blocking the VEGFR-2 Signaling Pathway

OBJECTIVES: Licoflavone A (LA) is a natural flavonoid compound derived from the root of Glycyrrhiza. This study investigated the antitumor effect and underlying molecular mechanisms of LA against gastric cancer (GC) in vitro and in vivo. MATERIALS AND METHODS: A CCK8 assay was used to measure the an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hongxia, Gong, Xiaojie, Jin, Guangxian, Leng, Min, Zhang, Shiwei, Niu, Wangjie, Cao, Han, Zhang, Yuanding, Zeng, Chenghao, Li, Yaling, Li, Yun, Su, Yongqi, Liu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061026/ https://www.ncbi.nlm.nih.gov/pubmed/35509849 http://dx.doi.org/10.1155/2022/5497991

Ejemplares similares

VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer
por: Lian, Lian, et al.
Publicado: (2019)

Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Jujuboside B suppresses angiogenesis and tumor growth via blocking VEGFR2 signaling pathway
por: Zhang, Pan, et al.
Publicado: (2023)

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway
por: Yang, Ting, et al.
Publicado: (2021)

Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model
por: Yashiro, M, et al.
Publicado: (2009)

SAIF plays anti-angiogenesis via blocking VEGF-VEGFR2-ERK signal in tumor treatment
por: Xie, Junye, et al.
Publicado: (2023)

Saikosaponin A, a Triterpene Saponin, Suppresses Angiogenesis and Tumor Growth by Blocking VEGFR2-Mediated Signaling Pathway
por: Zhang, Pan, et al.
Publicado: (2021)

Association between VEGFR-3 expression and lymph node metastasis in non-small-cell lung cancer
por: LI, JIE, et al.
Publicado: (2015)

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma
por: Jinnin, Masatoshi, et al.
Publicado: (2008)

Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects
por: Chang, Yi-Wen, et al.
Publicado: (2014)

DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation
por: Huang, Xionggao, et al.
Publicado: (2017)

Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling
por: Qin, Tingting, et al.
Publicado: (2020)

Inhibition of FNDC1 suppresses gastric cancer progression by interfering with Gβγ-VEGFR2 complex formation
por: Lu, Yao, et al.
Publicado: (2023)

Correlation among VEGFR3 gene promoter methylation, protein overexpression, and clinical pathology in early gastric cancer
por: Li, Xiu-Feng, et al.
Publicado: (2020)

Expression levels of VEGF-C and VEGFR-3 in renal cell carcinoma and their association with lymph node metastasis
por: Li, Xiuming, et al.
Publicado: (2021)

Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
por: Li, Jia, et al.
Publicado: (2019)

Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma
por: Yuan, Xiao-Han, et al.
Publicado: (2018)

Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma
por: ZHANG, ZHI, et al.
Publicado: (2016)

15-PGDH Expression in Gastric Cancer: A Potential Role in Anti-Tumor Immunity
por: Li, Yaling, et al.
Publicado: (2020)

Correlation of Vascular Endothelial Growth Factor-D Expression and VEGFR-3-Positive Vessel Density with Lymph Node Metastasis in Gastric Carcinoma
por: Choi, Jung-Hye, et al.
Publicado: (2008)

The regulatory mechanism and biological significance of the Snail-miR590-VEGFR-NRP1 axis in the angiogenesis, growth and metastasis of gastric cancer
por: Mei, Bin, et al.
Publicado: (2020)

Prognostic value and association of Lauren classification with VEGF and VEGFR-2 expression in gastric cancer
por: Li, Xiayi, et al.
Publicado: (2019)

Erratum to correlation among VEGFR3 gene promoter methylation, protein overexpression, and clinical pathology in early gastric cancer
por: Li, Xiu-Feng, et al.
Publicado: (2020)

Soluble Vegfr3 gene therapy suppresses multi‐organ metastasis in a mouse mammary cancer model
por: Shibata, Masa‐Aki, et al.
Publicado: (2020)

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
por: Song, Fei, et al.
Publicado: (2020)

Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3
por: Alishekevitz, Dror, et al.
Publicado: (2016)

AAV-CRISPR/Cas9–Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro
por: Wu, Wenyi, et al.
Publicado: (2017)

Quinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt/mTOR /p70s6k signaling pathway
por: Li, Zeng, et al.
Publicado: (2016)

Gastric cancer with breast metastasis: Clinical features and prognostic factors
por: Ma, Yue, et al.
Publicado: (2018)

Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer
por: Yang, Ju, et al.
Publicado: (2019)

Different but synergistic effects of bone marrow-derived VEGFR2(+) and VEGFR2(−)CD45(+) cells during hepatocellular carcinoma progression
por: Zhu, Xiaolin, et al.
Publicado: (2017)

Influence of VEGFR single nucleotide polymorphisms on the efficacy of sunitinib therapy against renal cell carcinoma
por: Liu, Rui, et al.
Publicado: (2017)

Limonin inhibits angiogenesis and metastasis of human breast cancer cells by suppressing the VEGFR2/IGFR1-mediated STAT3 signaling pathway
por: Chen, Jing, et al.
Publicado: (2020)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells
por: Wang, Lumin, et al.
Publicado: (2018)

MicroRNA-206 suppresses gastric cancer cell growth and metastasis
por: Ren, Jun, et al.
Publicado: (2014)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model
por: He, Shuning, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_e721pfpn9a3opl64irt8v4pcf3